F.D.A. Panel Unanimously Recommends Johnson & Johnson Booster Shots

But many panel members said J.& J. recipients might also benefit from the option of a Pfizer-BioNTech or Moderna booster, an action that an F.D.A. official said was possible.

Source: NYT Health - October 16, 2021 Category: Consumer Health News Authors: Sharon LaFraniere, Noah Weiland and Carl Zimmer Tags: Johnson & Vaccination and Immunization Coronavirus (2019-nCoV) Food and Drug Administration Centers for Disease Control and Prevention Moderna Inc Pfizer Inc Regulation and Deregulation of Industry Source Type: news